Piu Medical SpA (MIL:PMED) Research & Development: € Mil (TTM As of Jun. 2025)


MIL:PMED Piu Medical SpA MIL:PMED
13 GF Score
Price €5.25
! 4 Warning Signs
View Full Analysis

What is Piu Medical SpA Research & Development?

Piu Medical SpA MIL:PMED 13 Research & Development is € Mil as of Jun. 2025. GuruFocus rates MIL:PMED with a GF Score™ of 13/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Piu Medical SpA's Research & Development for the six months ended in Jun. 2025 was €0.00 Mil. Piu Medical SpA does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in Jun. 2025.

Piu Medical SpA  (MIL:PMED) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Piu Medical SpA Research & Development Related Terms

Piu Medical SpA Research & Development Historical Data

* Premium members only.

The historical data trend for Piu Medical SpA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Piu Medical SpA Research & Development Chart

Piu Medical SpA Annual Data
Trend Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00

Piu Medical SpA Semi-Annual Data
Dec23 Dec24 Jun25 Dec25
Research & Development 0.00 0.00 0.00 0.00
MIL:PMED
13GF Score
Piu Medical SpA MIL:PMED
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Piu Medical SpA Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of € Mil mean?
Piu Medical SpA (MIL:PMED) has a Research & Development of € Mil as of Jun. 2025. Research and development expense is the total cost for research and development activities. View historical data on Piu Medical SpA and its competitors.
Is Piu Medical SpA's Research & Development too high?
Piu Medical SpA's current Research & Development is € Mil. Overall, Piu Medical SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's Research & Development compare to competitors?
Piu Medical SpA's Research & Development of € Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Piu Medical SpA and its competitors. Piu Medical SpA's current Research & Development is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (MIL:PMED) has a current Research & Development of € Mil. The current Research & Development is € Mil. Piu Medical SpA's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Piu Medical SpA (MIL:PMED), the current Research & Development is € Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Piu Medical SpA Business Description

Address Viale LombardiA 62, Castronno, ITA, IT-21040
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
13GF Score

Get the complete analysis for MIL:PMED

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.25
Price